Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Betaloc CR 23.75
Active Ingredient(s): Metoprolol succinate 23.75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: AstraZeneca Limited
Manufacturer(s): AstraZeneca AB, Sodertalje, Sweden
Product: Ranihexal
Active Ingredient(s): Ranitidine hydrochloride 11.2mg/mL equivalent to 10mg/mL ranitidine
Dosage Form: Solution for injection
New Zealand Sponsor: Hexal New Zealand Pty Limited
Manufacturer(s): Weimer Pharma GmbH, Rastatt, Germany
Product: Tofranil
Active Ingredient(s): Imipramine hydrochloride 25mg
Dosage Form: Coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer(s): Novartis Pharma Canada Inc, Whitby, Ontario, Canada
Dated this 25th day of January 2001.
GILLIAN GREW, Acting Chief Advisor, Safety and Regulation (pursuant to delegation given by the Minister of Health on the
20th day of February 1997).